哮喘患者非依从性与非持续性程度：基于大型索赔数据集的分析

数据集获取（Figshare）

• 源站标题：Extent of non-adherence and non-persistence in asthma patients: analysis of a large claims data set
• DOI：10.6084/m9.figshare.13615840.v1
• 发布日期：2021-01-20
• 文件数：2 个
• 文件总体积：83.62 KB
• 源站页面：https://tandf.figshare.com/articles/dataset/Extent_of_non-adherence_and_non-persistence_in_asthma_patients_analysis_of_a_large_claims_data_set/13615840

命令行下载

curl -L -o "ijas_a_1871738_sm9670.docx" "https://ndownloader.figshare.com/files/26132938"
curl -L -o "ijas_a_1871738_sm8985.pdf" "https://ndownloader.figshare.com/files/26132941"

文件清单

• ijas_a_1871738_sm9670.docx（14.22 KB）
• ijas_a_1871738_sm8985.pdf（69.40 KB）

文件总体积 83.62 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

The objective of this study was to assess non-adherence (NA) and non-persistence (NP) to long-acting asthma medications in Germany by differentiating between measurement of NA in periods of therapy continuation and measurement of NP in therapy-naïve patients.
We analyzed treatment adherence to long-acting asthma medication using German claims data for periods of treatment continuation based on the medication possession ratio (MPR) and the proportion of days covered. Persistence was assessed in treatment-naïve patients. Outcomes were observed from the date of the first to the last prescription within a 12-month period. Both NA and NP analyses considered prescription supply, using either defined daily dosages, or prescribed daily dosages derived from a medical chart review.
We identified 52,508 asthma patients (mean age: 40.1, 58.4% female) who received at least two long-acting asthma prescriptions within 12 months; 50,660 treatment-naïve patients were included in the NP analysis (mean age: 39.7, 58.8% female). The mean 12-month MPR was 38.5% (89.4% NA according to MPR ≤ 80%) and the average proportion of days covered was 40.4% (85.9% NA). Agent-specific MPR and NA rates varied between 31.8% (91.8% NA) and 56.2% (71.6% NA). The average weighted-MPR increased to 53.1% when using the prescribed daily dosage. Based on a > 90-day gap definition, 86.7% of patients were considered non-persistent after 12 months (>180: 72.3%). When using prescribed daily dosages, NP rates ranged from 66.7 to 78.5%.
High levels of treatment NA and NP indicate a substantial need to improve adherence and persistence to long-acting asthma medication in Germany.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.13615840.v1（source: https://tandf.figshare.com/articles/dataset/Extent_of_non-adherence_and_non-persistence_in_asthma_patients_analysis_of_a_large_claims_data_set/13615840）。